Skip to main content

Global Navigation

  • Other sites:
  • ECDC
  • European Antibiotic Awareness Day
  • ESCAIDE - Scientific conference
  • Eurosurveillance journal
  • EVIP - Vaccination portal
European Centre for Disease Prevention and Control

European Centre for Disease Prevention and Control

An agency of the European Union

Main Navigation

  • Home
  • All topics: A to Z

Secondary Navigation

  • News & events
  • Publications & data
  • Tools
  • About us
  • Search

Search

Filter by
  • Filter by
  • Remove this filter Type: Surveillance report
  • Remove this filter Public health area: Surveillance
  • Infectious disease
    • Vaccine preventable diseases (367)
    • Respiratory diseases (206)
    • Influenza (183)
    • Zoonosis (143)
    • Food- and waterborne diseases (129)
    • Influenza in humans, seasonal (99)
    • Seasonal influenza (99)
    • Flu (99)
    • Mosquito-borne diseases (79)
    • Measles (78)
    • Rubella (63)
    • German measles (63)
    • Sexually transmitted infections (61)
    • Viral haemorrhagic fever (48)
    • Avian influenza virus (42)
    • Zoonotic influenza (42)
    • Poliomyelitis (34)
    • Ebola haemorrhagic fever (32)
    • Viral hepatitis (31)
    • Influenza in humans, avian origin (28)
    • Middle East respiratory syndrome coronavirus (25)
    • Tuberculosis (23)
    • Legionnaires’ disease (23)
    • West Nile virus infection (23)
    • Chikungunya virus disease (23)
    • Healthcare-associated infections (23)
    • Avian influenza in humans (23)
    • Influenza A (H9N2) (23)
    • Salmonellosis (20)
    • Dengue (20)
    • Zika virus disease (20)
    • HIV infection (18)
    • Acquired immunodeficiency syndrome (AIDS) (18)
    • Influenza in humans, swine origin (15)
    • Campylobacteriosis (15)
    • Escherichia coli infection (15)
    • Chlamydia infection (14)
    • Yellow fever (13)
    • Hepatitis A (13)
    • Hospital-acquired infections (13)
    • Syphilis (12)
    • Whooping cough (12)
    • Pertussis (12)
    • Yersiniosis (12)
    • Listeriosis (11)
    • Tick-borne diseases (11)
    • Tularaemia (11)
    • Cholera (11)
    • Enterohaemorrhagic Escherichia coli (EHEC) infection (11)
    • Mumps (10)
    • Influenza A(H7N9) virus (10)
    • Nosocomial infections (10)
    • Gonorrhoea (10)
    • Hepatitis B (10)
    • Rabies (10)
    • Trichinellosis (10)
    • Q fever (10)
    • Shigellosis (9)
    • Toxoplasmosis, congenital (9)
    • Verotoxigenic Escherichia coli infection (9)
    • Multidrug-resistant tuberculosis (9)
    • Shiga toxin producing Escherichia coli (STEC) infection (9)
    • Verocytotoxigenic Escherichia coli (VTEC) infection (9)
    • Influenza A(H5N8) virus (8)
    • Invasive meningococcal disease (8)
    • Hydatidosis (8)
    • Hepatitis C (8)
    • Meningococcal disease (8)
    • Echinococcosis (8)
    • Brucellosis (8)
    • Malaria (8)
    • Haemophilus infection (7)
    • Influenza A(H5N1) virus (7)
    • S. pneumoniae (7)
    • Streptococcus pneumoniae (7)
    • Invasive pneumococcal disease (7)
    • Paratyphoid fever (7)
    • Enteric fever (7)
    • Pneumococcal disease (7)
    • Surgical site infections (7)
    • Invasive Haemophilus influenzae disease (7)
    • Rift Valley fever (7)
    • Typhoid and paratyphoid fever (7)
    • Haemorrhagic fever with renal syndrome (6)
    • Influenza A(H5N2) virus (6)
    • Hantavirus infection (6)
    • Marburg virus diseases (6)
    • Nephropathia epidemica (6)
    • Diphtheria (6)
    • Infections in intensive care units (6)
    • Marburg haemorrhagic fever (6)
    • Smallpox (6)
    • Tick-borne encephalitis (TBE) (6)
    • Plague (6)
    • Syphilis, congenital (5)
    • Congenital syphilis (5)
    • Lymphogranuloma venereum (5)
    • Lassa fever (5)
    • Crimean-Congo haemorrhagic fever (5)
    • Vector-borne disease (5)
    • Emerging disease (5)
    • Cryptosporidiosis (5)
    • Botulism (5)
    • Tetanus (5)
    • Giardiasis (5)
    • Anthrax (4)
    • Leptospirosis (4)
    • Variant Creutzfeldt-Jakob disease (vCJD) (4)
    • Varicella (4)
    • Creutzfeldt-Jakob disease (4)
    • Chickenpox (4)
    • Influenza A (H1N1) (4)
    • Ebola outbreak - North Kivu, DRC (4)
    • Influenza A (H1N1)2009 (3)
    • Extensively drug-resistant tuberculosis (XDR-TB) (3)
    • Severe acute respiratory syndrome (SARS) (3)
    • Influenza in humans, pandemic (3)
    • Zika virus disease - Outbreak in the Americas (2)
    • Infections in long-term care facilities (2)
    • Hepatitis (2)
    • Drug-resistant tuberculosis (1)
    • Influenza A(H5N6) (1)
    • Coxsackievirus (1)
    • Infections in acute care hospitals (1)
    • Extrapulmonary tuberculosis (1)
    • Enterovirus (1)
    • Methicillin-resistant Staphylococcus aureus (MRSA) (1)
    • Clostridium difficile infection (1)
    • Louse-borne diseases (1)
    • Norovirus infection (1)
    • Hepatitis E (1)
    • Latent tuberculosis infection (1)
  • Public health area
    • Surveillance (616)
    • Public health threat (48)
    • Outbreak (48)
    • Threats and outbreaks (48)
    • Immunisation (38)
    • Vaccination (38)
    • Active immunisation (38)
    • Antimicrobial resistance (20)
    • Antibiotic resistance (20)
    • Laboratory based surveillance (15)
    • Antimicrobial consumption (13)
    • Microbiology (10)
    • Laboratories (3)
    • Mass gathering (3)
    • Epidemic intelligence (2)
    • Molecular typing (2)
    • Epidemiology (1)
    • Determinant (1)
    • Climate change (1)
    • Travellers' health (1)
    • People who inject drugs (PWID) (1)
    • Infectious diseases on aircrafts (1)
    • Intensive care unit (ICU) (1)
    • Intravenous drug users (1)
    • Injecting drug users (IDUs) (1)
  • Country
    • Europe (432)
    • Asia (27)
    • Africa (19)
    • Americas (12)
    • North America (1)
    • Pacific regions (1)
  • Media type
    • Surveillance report (616)
    • Publication (616)
    • Technical report (4)
    • External quality assessment (4)
  • Page 1 of 62 // 616 Results found
    • Sort by:

Publication

Hantavirus infection - Annual Epidemiological Report for 2019

Surveillance report - 22 Apr 2021

For 2019, 29 countries reported 4 046 cases of hantavirus infection (0.8 cases per 100 000 population), mainly caused by Puumala virus (98%).

Hantavirus infection - Annual Epidemiological Report for 2019 - EN - [PDF-874.06 KB]
  • Hantavirus infection
  • Surveillance

Publication

Malaria - Annual Epidemiological Report for 2019

Surveillance report - 22 Apr 2021

For 2019, 8 641 malaria cases were reported in the EU/EEA, 8 638 (> 99%) of which were confirmed.

Malaria - Annual Epidemiological Report for 2019 - EN - [PDF-950.27 KB]
  • Malaria
  • Surveillance

Publication

Influenza virus characterisation - Summary Europe, March 2021

Surveillance report - 21 Apr 2021

This is the fifth report for the 2020-2021 influenza season. As of week 12/2021, only 758 influenza detections across the WHO European Region had been reported to The European Surveillance System (TESSy); 50% type A viruses, with A(H3N2) and A(H1N1)pdm09 being equally represented, and 50% type B viruses, with only 12 having been ascribed to a lineage, 10 B/Victoria and two B/Yamagata.

Influenza virus characterisation - Summary Europe, March 2021 - EN - [PDF-2.19 MB]
  • EU/EEA
  • Influenza
  • Influenza in humans, seasonal
  • Surveillance

Publication

Chikungunya virus disease - Annual Epidemiological Report for 2019

Surveillance report - 14 Apr 2021

For 2019, 15 countries reported 516 cases of chikungunya virus disease, of which 421 (82%) were confirmed.

Chikungunya virus disease - Annual Epidemiological Report for 2019 - EN - [PDF-494.23 KB]
  • Chikungunya virus disease
  • EU/EEA
  • Surveillance

Publication

Dengue - Annual Epidemiological Report for 2019

Surveillance report - 14 Apr 2021

For 2019, 27 countries reported 4 363 cases of dengue, of which 4 020 (92%) were confirmed. • The number of cases in 2019 was almost double that for 2018, reflecting the intense circulation of the virus on a global scale.

Dengue- Annual Epidemiological Report for 201 9 - EN - [PDF-504.57 KB]
  • Dengue
  • EU/EEA
  • Surveillance

Publication

Zika virus disease - Annual Epidemiological Report for 2019

Surveillance report - 24 Mar 2021

For 2019, in the EU/EEA countries, 71 cases of Zika virus (ZIKV) disease were reported. Five cases of ZIKV disease were reported to have been locally-acquired, three autochthonous vector-borne cases, one case of sexual transmission and one case of non-mosquito borne transmission. 92% of cases of ZIKV disease with known importation status were from returning travellers.

Zika virus disease - Annual Epidemiological Report for 2019 - EN - [PDF-630.27 KB]
  • EU/EEA
  • Surveillance
  • Zika virus disease

Publication

Tick-borne encephalitis - Annual Epidemiological Report for 2019

Surveillance report - 24 Mar 2021

For 2019, twenty-five EU/EEA countries reported 3 411 cases of tick-borne encephalitis (TBE), 3 246 (95.2%) of which were confirmed.

Tick-borne encephalitis - Annual Epidemiological Report for 2019 - EN - [PDF-518.13 KB]
  • EU/EEA
  • Surveillance
  • Tick-borne encephalitis (TBE)

Publication

Tuberculosis surveillance and monitoring in Europe 2021 –2019 data

Surveillance report - 22 Mar 2021

This report provides an overview of the latest TB epidemiological situation and is published jointly by the WHO Regional Office for Europe and the European Centre for Disease Prevention and Control (ECDC).

Tuberculosis surveillance and monitoring in Europe 2020 –2019 data - EN - [PDF-15.44 MB]
  • Drug-resistant tuberculosis
  • EU/EEA
  • Europe
  • Extensively drug-resistant tuberculosis (XDR-TB)
  • Extrapulmonary tuberculosis
  • Latent tuberculosis infection
  • Multidrug-resistant tuberculosis
  • Surveillance
  • Tuberculosis

Publication

West Nile virus infection - Annual Epidemiological Report for 2019

Surveillance report - 19 Mar 2021

For 2019, eleven EU/EEA Member States reported 443 West Nile virus infections, 425 (96%) of which were locally-acquired.

West Nile virus infection - Annual Epidemiological Report for 2019 - EN - [PDF-820.33 KB]
  • EU/EEA
  • Surveillance
  • West Nile virus infection

Publication

Influenza virus characterisation - Summary Europe, February 2021

Surveillance report - 11 Mar 2021

This is the fourth report for the 2020-2021 influenza season. As of week 8/2021, only 712 influenza detections across the WHO European Region had been reported to TESSy; 51% type A viruses, with A(H3N2) and A(H1N1)pdm09 being equally represented, and 49% type B viruses, with only 10 having been ascribed to a lineage, eight B/Victoria and two B/Yamagata.

Influenza virus characterisation Summary Europe, February 2021 - EN - [PDF-9 MB]
  • EU/EEA
  • Influenza
  • Influenza in humans, seasonal
  • Surveillance

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Next page ››
  • Last page Last »
  • About us

    • What we do
    • Who we are
    • Governance
  • Work with us

    • Vacancies
    • Fellowships
    • Traineeships
    • Procurement and grants
  • Contact ECDC

    • Visit us
    • ECDC press room
    • Social media
Log in to ECDC Extranet
Newsletter RSS

Follow us:

Facebook Twitter Youtube Linked In Vimeo Slide share

Footer Navigation

  • Legal notice
  • Copyright
  • Access to TESSy
  • Personal data protection
  • Language policy
  • Cookies
  • Accessibility
  • Sitemap
© European Centre for Disease Prevention and Control (ECDC) 2021
  • Other sites:
    • ECDC
    • European Antibiotic Awareness Day
    • ESCAIDE - Scientific conference
    • Eurosurveillance journal
    • EVIP - Vaccination portal
  • Home
  • All topics: A to Z
  • News & events
  • Publications & data
  • Tools
  • About us